CHAMPIONS ONCOLOGY, INC. Logo

CHAMPIONS ONCOLOGY, INC.

Oncology CRO accelerating drug development with PDX models and multi-omic data analytics.

CSBR | NDAQ

Overview

Corporate Details

ISIN(s):
US15870P3073
LEI:
549300O8WKLP8QEG5U47
Country:
United States of America
Address:
855 N. WOLFE STREET, 21205 BALTIMORE
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Champions Oncology, Inc. is a global contract research organization (CRO) specializing in end-to-end oncology drug development solutions. The company partners with pharmaceutical and biotech firms to accelerate research from discovery to clinical success. Its core offerings are built upon a proprietary, clinically relevant bank of over 1,400 patient-derived xenograft (PDX) models. This is integrated with a comprehensive multi-omic data platform, containing over two billion data points, accessible through its Lumin software for advanced analytics and visualization. Champions provides a suite of preclinical and clinical specialty testing services, including high-complexity flow cytometry, next-generation sequencing, histology, and radiopharmaceutical development, enabling data-driven decisions and biomarker discovery.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all CHAMPIONS ONCOLOGY, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CHAMPIONS ONCOLOGY, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CHAMPIONS ONCOLOGY, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
AngioLab, Inc. Logo
Develops anti-angiogenic therapeutics and foods for angiogenesis-related diseases.
South Korea 251280
Anixa Biosciences Inc Logo
Clinical-stage biotech developing CAR-T immunotherapies and vaccines to fight cancer.
United States of America ANIX
Annovis Bio, Inc. Logo
Developing oral therapies for neurodegenerative diseases like Alzheimer's and Parkinson's.
United States of America ANVS
Aoyama Zaisan Networks Company,Limited Logo
Consulting on inheritance and business succession for individuals and corporations.
Japan 8929
APG SGA SA Logo
Switzerland's leading OOH media firm offering digital and analogue outdoor advertising solutions.
Switzerland APGN.SW
Biotech R&D using a miniature pig model, offering CRO services and biomaterials to pharma.
South Korea 149300
ARM HOLDINGS PLC /UK Logo
Licenses energy-efficient CPU IP for AI, mobile, automotive, IoT, and cloud markets.
United States of America ARM
Arterra Bioscience Logo
Develops natural active ingredients via biotechnology for cosmetic, pharma, and food sectors.
Italy ABS
ARVINAS, INC. Logo
Develops protein degradation drugs for oncology & neuroscience, targeting undruggable proteins.
United States of America ARVN
ASUA Inc. Logo
Consulting and solutions provider enhancing logistics safety and efficiency with IoT and telecom.
Japan 246A

Talk to a Data Expert

Have a question? We'll get back to you promptly.